Spironolactone
Product Images NDC 68071-2936

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 68071-2936). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2936 3)

Pdp (68071 2936 3)
Label for Spironolactone 50 mg tablets by NuCare Pharmaceuticals, Inc. The label identifies the product as containing 30 tablets. It describes the tablets as oval, white to off-white, scored, convex, with "853" and "O" debossed on opposite sides. Prescription only, with storage instructions to keep at 68-77°F and warnings to keep out of reach of children.*
FDA Label Image

Figure 1 (Figure1)

Figure 1 (Figure1)
A Kaplan-Meier survival curve comparing Spironolactone and Placebo groups over months. The chart shows probability on the y-axis and months on the x-axis, with separate curves for Spironolactone (n=822) and Placebo (n=841). A log-rank p-value of less than 0.001 is noted.*
FDA Label Image

Figure 2 (Figure2)

Figure 2 (Figure2)
A forest plot chart illustrating subgroup analyses of Spironolactone versus placebo. It shows hazard ratios (HR) and 95% confidence intervals (CI) for various patient subgroups including age, sex, race, LVEF percentage, heart failure type, NYHA classification, diabetes status, serum creatinine, creatinine clearance, potassium levels, and concurrent use of digoxin, ACE inhibitors, and beta blockers. The x-axis compares Spironolactone favorability on the left against placebo on the right.*
FDA Label Image

20 (Spironolactone Tablets Usp 1)

20 (Spironolactone Tablets Usp 1)
Chemical structure diagram of spironolactone showing its molecular arrangement with rings and functional groups including a lactone ring, methyl groups, and a thioacetate group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.